中国生物科技服务与多家保险公司签署BNCT保险合作备忘录

财中社
11 Jul

7月11日,中国生物科技服务(08037)发布公告,宣布与AXA安盛香港、安盛环球再保险、前海再保险及安睿嘉尔签署了一份不具法律约束力的谅解备忘录,旨在共同开发覆盖硼中子治疗(BNCT)治疗费用及相关服务的普惠型医疗保险产品。此次合作的主要目标是降低患者的经济负担,提高治疗的可及性。在此次合作中,公司将作为BNCT治疗服务及相关第三方理赔管理服务的提供者,而AXA安盛香港将负责香港地区的直保业务,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10